(Total Views: 203)
Posted On: 02/23/2019 7:19:22 AM
Post# of 36570
https://seekingalpha.com/article/4243546-gene...end-shares
Thomas Barnard assesses NGIO shares at $2. Compares NGIO to recent purchase by Merck of another immunotherapy company.
Thomas Barnard assesses NGIO shares at $2. Compares NGIO to recent purchase by Merck of another immunotherapy company.
(0)
(0)
